News and Announcements

New test could sharply reduce risky, costly lung cancer biopsies

May 18th, 2015 in Press Release, Publications.

Press Release: May 18, 2015 | Written by Lenny Bernstein - The Washington Post When a suspicious lesion shows up in the lungs on a CT scan, the first thing your doctor wants to know is whether it's cancerous. A specialist will pass a long, thin bronchoscope into your airway in the hope of... More

Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier

April 30th, 2015 in Press Release.

Press: April 16, 2015 | Veracyte South San Francisco, Calif. --- April 16, 2015 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta™ Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The... More

Behind the Vapor – Chasing the facts behind e-cigarette health risks

October 22nd, 2014 in Press Release.

Press: October 20, 2014; written by Sara Rimer | BU Research  With the public health community sharply divided over the potential benefit and harm of the popular device—and with conclusive scientific evidence in short supply—the World Health Organization (WHO) released a report in August 2014 that raised serious questions about the health impact... More

Researchers will study relation of environment to breast cancer

October 17th, 2014 in Press Release.

Press: October 16th 2014, written by Todd Feathers | Boston Globe Five eminent Boston researchers will officially join forces Thursday to tackle one of the most perplexing questions about breast cancer: Why do so many people with no family history of the disease get it? The researchers will examine whether common man-made... More

Veracyte to Acquire Allegro Diagnostics: Plans to Launch Lung Cancer Test

September 9th, 2014 in Press Release.

Press release: September 4th 2014  SOUTH SAN FRANCISCO, Calif., Sept. 4, 2014 /PRNewswire/ -- Veracyte, a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to acquire Allegro Diagnostics Corp. based in Maynard, Mass., for $21.0 million, comprised of $7.8 million in cash and $13.2 million in Veracyte... More

New way to determine cancer risk of chemicals found

August 25th, 2014 in Press Release, Publications.

Press Release from July 24th 2014 A new study has shown that it is possible to predict long-term cancer risk from a chemical exposure by measuring the short-term effects of that same exposure. The findings, which currently appear in the journal PLOS ONE, will make it possible to develop simpler and cheaper... More

BUSM Researchers Identify Molecule that Could Aid Lung Cancer Detection, Treatment

November 7th, 2013 in Press Release, Publications.

Press Release: From October 28th 2013 Written by Jenny C Leary Researchers at Boston University School of Medicine (BUSM) have discovered a molecule that could help lead to the non-invasive detection of lung cancer as well as its treatment. Using RNA sequencing, the team looked at airway epithelial cells and identified a... More

BUSM Researchers Identify Novel Approach to Study COPD and Treatment Efficacy

May 24th, 2013 in Publications.

Press Release: From April 11, 2013 Written By Jenny C Leary BUSM researchers have pinpointed a genetic signature for chronic obstructive pulmonary disease (COPD) from airway cells harvested utilizing a minimally invasive procedure. The findings provide a novel way to study COPD and could lead to new treatments and... More

Never Smoker Lung Cancer

January 24th, 2013 in Press Release.

Press Release : BU Today January 22 2013 Never Smoked. Lived Right. Died of Lung Cancer. By Rich Barlow Avrum Spira’s aunt died of lung cancer almost 20 years ago. She was a nonsmoking exercise buff in her 40s who hadn’t been exposed to any known toxins; she worked in a government office, More

How gene profiling in emphysema is helping to find a cure

October 12th, 2012 in Publications.

Press Release: BioMed Central August 31, 2012 Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States and is thought to affect almost three million people in the UK. New research published in BioMed Central’s open access journal Genome Medicine has... More